跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PLERIXAFOR INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PLERIXAFOR INJECTION
Authorized
STANDARD
PLERIXAFOR INJECTION
eugia pharma inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
fed32e4490be70fb
Company
eugia pharma inc.
Type
Standard
Approval Details
Approval Id
fed32e4490be70fb
Drug Approval Canada Name
PLERIXAFOR INJECTION
Product Name
PLERIXAFOR INJECTION
Status
Marketed
Status Date
2024-01-05
Original Market Date
2024-01-05
Din
02539454
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Prescription
Ahfs
20:16.00
Atc Original
L03AX16 PLERIXAFOR
Atc Name
l 03 ax 16
Aig Number
0153050001
Company Name
eugia pharma inc.
Company Address
3700 Steeles Avenue West, Suite 402, Woodbridge, Ontario, Canada, L4L 8K8
Active Ingredients
PLERIXAFOR
20 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
fed32e4490be70fb
Type
Standard
Back to Health Canada Approvals